KULHAN, N. G. Et Al. 2019. Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?. GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.9 , 796-802.

KULHAN, N. G., KULHAN, M., Aydin, M., Nayki, U., NAYKI, C., ULUĞ, P., ... ATA, N.(2019). Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?. GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.9, 796-802.

KULHAN, NUR Et Al. "Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?," GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.9, 796-802, 2019

KULHAN, NUR G. Et Al. "Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?." GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.9, pp.796-802, 2019

KULHAN, N. G. Et Al. (2019) . "Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?." GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.9, pp.796-802.

@article{article, author={NUR GÖZDE KULHAN Et Al. }, title={Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?}, journal={GYNECOLOGICAL ENDOCRINOLOGY}, year=2019, pages={796-802} }